MTAC vs NKTX
Comparison between MedTech Acquisition Corp - Class A (MTAC, Company) and Nkarta Inc (NKTX, Company).
MTAC vs NKTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
MTAC
$183M
NKTX
$183M
Max Drawdown
Winner
MTAC
13.92%
NKTX
98.27%
Sharpe Ratio
MTAC
0.44
Winner
NKTX
0.76
5Y Beta
MTAC
N/A
NKTX
1.35
Industry
MTAC
N/A
NKTX
Biotechnology
P/E Ratio
Winner
MTAC
-32.94
NKTX
-1.74
Debt to Equity
MTAC
0.00%
NKTX
0.00%
Free Cash Flow Yield
Winner
MTAC
-27.91%
NKTX
-48.39%
P/S Ratio
Winner
MTAC
12.43
NKTX
1000000.00
P/B Ratio
Winner
MTAC
-12.13
NKTX
0.62
MTAC vs NKTX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MTAC
+7.90%
NKTX
-12.80%
3M
MTAC
+9.99%
Winner
NKTX
+24.89%
6M
MTAC
+11.55%
Winner
NKTX
+52.13%
1Y
MTAC
+14.55%
Winner
NKTX
+49.74%
5Y(CAGR)
MTAC
N/A
NKTX
-35.19%
Max(CAGR)
Winner
MTAC
+3.05%
NKTX
-37.87%
MTAC vs NKTX - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | MTAC | NKTX |
|---|---|---|
| 2026 | N/A | +52.94% |
| 2025 | N/A | -26.00% |
| 2024 | N/A | -60.91% |
| 2023 | +12.84% | +9.45% |
| 2022 | +0.80% | -60.04% |
| 2021 | -6.08% | -74.25% |
| 2020 | N/A | +28.33% |
MTAC vs NKTX Drawdown Comparison
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The maximum drawdown for NKTX was -98.27%, occurring on Oct 2, 2023. This drawdown has not yet recovered.
The current NKTX drawdown is -96.22%.
| Rank | MTAC | NKTX |
|---|---|---|
| #1 | -13.92% Feb 19, 2021 - Aug 10, 2023 | -98.27% Dec 23, 2020 - Oct 2, 2023 |
| #2 | -1.90% Feb 8, 2021 - Feb 16, 2021 | -50.90% Jul 10, 2020 - Dec 7, 2020 |
| #3 | N/A | -12.82% Dec 10, 2020 - Dec 22, 2020 |
Correlation
Correlation between MTAC and NKTX is -0.42 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.42
-101
Select Stocks to Compare
Popular: MTAC vs SPYNKTX vs SPY
More Comparisons
Compare with similar stocks